LAUREL BIOTHERAPEUTICS
Live / Applied — First extension granted (statement of use) (as of 20 Oct 2025)
What this means for you
Not registered yet, but its 31 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98675319
- Mark type
- Stylized text
- Filed
- 31 Jul 2024
- Published for opposition
- 04 Mar 2025
- Attorney of record
- Daniel Chiafair
Goods and services
- Class 005 — Pharmaceuticals: House mark for a line of antibodies for medical purposes; House mark for a line of pharmaceutical preparations for the treatment and prevention of heart disease and other diseases; House mark for a line of therapeutic pharmaceuticals for the treatment of heart disease and other diseases
- Class 042 — Scientific and technological services: Pharmaceutical products development; Pharmaceutical research services; Research and development in the field of antibody therapeutics for the treatment of heart diseases and other diseases for medical purposes; Research and development in the pharmaceutical and biotechnology fields; Research and development services in the field of antibodies; Research and development services of new pharmaceutical products
Owner
- Laurel Biotherapeutics, Inc., Woburn, MA, US
- Laurel Biotherapeutics, Inc., Woburn, MA, US
Prosecution history
- 21 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Oct 2025 — SOU EXTENSION 1 GRANTED
- 20 Oct 2025 — SOU EXTENSION 1 FILED
- 20 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Mar 2025 — PUBLISHED FOR OPPOSITION
- 04 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Feb 2025 — ASSIGNED TO EXAMINER
- 16 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 Nov 2024 — TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
- 13 Nov 2024 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 31 Jul 2024 — NEW APPLICATION ENTERED